Ireland's MuteButton scores funding for tinnitus device

Spin-out company MuteButton has secured €200,000 (approximately $289,500) in funding from Enterprise Ireland, allowing it to accelerate large-scale trials of its tinnitus treatment device and increase its workforce from four to 20 by 2013. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.